` SUS (Surgical Science Sweden AB) vs OMX Stockholm 30 Comparison - Alpha Spread

SUS
vs
OMX Stockholm 30

Over the past 12 months, SUS has underperformed OMX Stockholm 30, delivering a return of -7% compared to the OMX Stockholm 30's 5% drop.

Stocks Performance
SUS vs OMX Stockholm 30

Loading

Performance Gap
SUS vs OMX Stockholm 30

Loading
SUS
OMX Stockholm 30
Difference

Performance By Year
SUS vs OMX Stockholm 30

Loading
SUS
OMX Stockholm 30
Add Stock

Competitors Performance
Surgical Science Sweden AB vs Peers

OMX Stockholm 30
SUS
ABT
ISRG
BSX
SYK
Add Stock

Surgical Science Sweden AB
Glance View

Market Cap
6.7B SEK
Industry
Health Care

Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2017-06-19. The systems comprise LapSim, EndoSim and TeamSim trainings. Each training combine graphics and cognitive instruction, imply navigation on touch screens and feature tactile feedback technology. The LapSim trainings consist of laparoscopic exercises that range from basic navigation to advanced suturing, the EndoSim endoscopic exercises range from functions of the scope handle and tube, to loop reduction. The TeamSim comprises procedure modules to train in a real world operation room environment and helps to build team communication skills in crisis and routine situations. The training systems are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors.

SUS Intrinsic Value
185.22 SEK
Undervaluation 29%
Intrinsic Value
Price
S
Back to Top